ArticleBMC cancer2023

Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.

Nadia Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.